The 22 funding announcements we tracked by orthopaedic companies in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult.
The companies and technologies that will lead orthopaedics in 2025 are those that are able to assist hospital and surgeon customers in solving their problems and achieving their objectives.
ASC owns a proprietary platform of Multipotent Adult Stem Cells (MASCs) that can differentiate into cartilage, bone, tendon, muscle, ligaments, etc. and has developed Chondrofelt, a matrix intended for use in microfracture to repair articular cartilage defects.
Strong demand for 3D-printed products is a consistently-cited growth driver for Stryker, and in early 2017, leadership affirmed that a number of new 3D-printed products are slated for launch this year. The GE partnership will assist with machines and materials to ramp up manufacturing.
EU Medical Device Regulation, Additive Manufacturing, Raw Materials, QMS, FDA Updates, DFM. These subjects and more are covered in presenter slides, available now.
FDA released 56 orthopaedic-related 510(k)s last month. Details on a locking plate, next-gen meniscus repair implant, SI joint fusion device and total hip are presented here.
iTotal Hip is supported by iFit "Image-to-Implant" technology to develop and manufacture cutting jigs and implants, similar to what is used to design CFMS' customized knee implants; iTotal also employs single-use 3D printed instruments and a just-in-time delivery model.
